Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.
Di Carlo D, Annereau M, Vignes M, Denis L, Epaillard N, Dumont S, Guyon D, Rieutord A, Jacobs S, Salomon V, Yoldjian I, Duperray F, Brunel L, Baiao X, Lemos F, Vauleon E, Capra M, Abbou S, Touat M, Sanson M, Gandemer V, De Carli E, Bourdeaut F, Hezam I, Vassal G, Grill J. Di Carlo D, et al. Among authors: touat m. Eur J Cancer. 2024 Dec 11;216:115165. doi: 10.1016/j.ejca.2024.115165. Online ahead of print. Eur J Cancer. 2024. PMID: 39700833 Free article.
Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study.
Berthet E, Guillonnet A, Houillier C, Ursu R, Soussain C, Touat M, Gueguen A, de Renzis B, Bigaut K, Ahle G, Durozard P, Grosset-Janin D, Oberic L, Bonnet A, Grandjean AP, Moluçon-Chabrot C, Hoang-Xuan K, Chabriat H, Guey S. Berthet E, et al. Among authors: touat m. Ann Neurol. 2024 Nov 28. doi: 10.1002/ana.27132. Online ahead of print. Ann Neurol. 2024. PMID: 39605186
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology consensus review on diagnosis, management, and future directions.
Lim-Fat MJ, Bennett J, Ostrom Q, Touat M, Franceschi E, Schulte J, Bindra RS, Fangusaro J, Dhall G, Nicholson J, Jackson S, Davidson TB, Calaminus G, Robinson G, Whittle JR, Hau P, Ramaswamy V, Pajtler KW, Rudà R, Foreman NK, Hervey-Jumper SL, Das S, Dirks P, Bi WL, Huang A, Merchant TE, Fouladi M, Aldape K, Van den Bent MJ, Packer RJ, Miller JJ, Reardon DA, Chang SM, Haas-Kogan D, Tabori U, Hawkins C, Monje M, Wen PY, Bouffet E, Yeo KK. Lim-Fat MJ, et al. Among authors: touat m. Neuro Oncol. 2024 Oct 23:noae186. doi: 10.1093/neuonc/noae186. Online ahead of print. Neuro Oncol. 2024. PMID: 39441704
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: lessons from the French POLA cohort.
Figarella-Branger D, Colin C, Mokhtari K, Uro-Coste E, Idbaih A, Appay R, Tabouret E, Touat M, Seyve A, Carpentier C, Dehais C, Ducray F; POLA network. Figarella-Branger D, et al. Among authors: touat m. Neuro Oncol. 2024 Oct 21:noae221. doi: 10.1093/neuonc/noae221. Online ahead of print. Neuro Oncol. 2024. PMID: 39432559
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection - Update 1.
van den Bent MJ, Franceschi E, Touat M, French PJ, Idbaih A, Lombardi G, Rudaà R, Schweizer L, Capper D, Sanson M, Wesseling P, Weller M, Eoli M, Anghileri E, Bielle F, Euskirchen P, Geurts M, Wen PY, Preusser M. van den Bent MJ, et al. Among authors: touat m. Neuro Oncol. 2024 Oct 10:noae213. doi: 10.1093/neuonc/noae213. Online ahead of print. Neuro Oncol. 2024. PMID: 39387386
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C, Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E, Langlois O, Campone M, Ducloie M, Noel G, Cuzzubbo S, Taillandier L, Ramirez C, Younan N, Menei P, Dhermain F, Desenclos C, Ghiringhelli F, Bourg V, Ricard D, Faillot T, Appay R, Tabouret E, Nichelli L, Mathon B, Thomas A, Tran S, Bielle F, Alentorn A, Iorgulescu JB, Boëlle PY, Labreche K, Hoang-Xuan K, Sanson M, Idbaih A, Figarella-Branger D, Ducray F, Touat M; POLA Network. Kacimi SEO, et al. Among authors: touat m. J Clin Oncol. 2024 Oct 2:JCO2400049. doi: 10.1200/JCO.24.00049. Online ahead of print. J Clin Oncol. 2024. PMID: 39356975
Advances in the treatment of IDH-mutant gliomas.
Baek C, Laurenge A, Touat M. Baek C, et al. Among authors: touat m. Curr Opin Neurol. 2024 Dec 1;37(6):708-716. doi: 10.1097/WCO.0000000000001316. Epub 2024 Sep 11. Curr Opin Neurol. 2024. PMID: 39253756 Review.
Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors.
Ghosh HS, Patel RV, Woodward E, Greenwald NF, Bhave VM, Maury EA, Cello G, Hoffman SE, Li Y, Gupta H, Youssef G, Spurr LF, Vogelzang J, Touat M, Dubois F, Cherniack AD, Guo X, Tavakol S, Cioffi G, Lindeman NI, Ligon AH, Chiocca EA, Reardon DA, Wen PY, Meredith D, Santagata S, Barnholtz-Sloan JS, Ligon KL, Beroukhim R, Bi WL. Ghosh HS, et al. Among authors: touat m. Neuro Oncol. 2024 Aug 21:noae164. doi: 10.1093/neuonc/noae164. Online ahead of print. Neuro Oncol. 2024. PMID: 39164213
105 results